These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2913267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
    Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Aug; 250(2):485-91. PubMed ID: 2760839
    [Abstract] [Full Text] [Related]

  • 3. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK, Stitzer ML, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X, Farre M, Cami J.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
    Preston KL, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ, Walsh SL, Bigelow GE, Preston KL, Stitzer ML.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [Abstract] [Full Text] [Related]

  • 11. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK, Bhateja P, Singh TG, Singh N.
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [Abstract] [Full Text] [Related]

  • 12. Acute physical dependence: time course and relation to human plasma morphine concentrations.
    June HL, Stitzer ML, Cone E.
    Clin Pharmacol Ther; 1995 Mar; 57(3):270-80. PubMed ID: 7697945
    [Abstract] [Full Text] [Related]

  • 13. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
    Preston KL, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074
    [Abstract] [Full Text] [Related]

  • 14. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [Abstract] [Full Text] [Related]

  • 15. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT, Little PJ, Kuhn CM.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A, Sorrentino L.
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [Abstract] [Full Text] [Related]

  • 20. Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.
    Azolosa JL, Stitzer ML, Greenwald MK.
    Psychopharmacology (Berl); 1994 Feb; 114(1):71-80. PubMed ID: 7846209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.